The Third People's Hospital of Taiyuan
14
3
3
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis
Role: collaborator
Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
Role: collaborator
Noninvasive Diagnosis Model for High-risk Varices in Cirrhosis
Role: collaborator
Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy
Role: collaborator
Non-invasive Diagnosis of Portal Hypertension in Cirrhosis Based on Metabolomics Technology
Role: collaborator
A Novel Spleen-dedicated Stiffness Measured by FibroScan to Evaluate Cirrhotic Portal Hypertension (CHESS2105)
Role: collaborator
Algorithm to Stratify Clinical Decompensation Risk in Patients With Compensated Advanced Chronic Liver Disease (CHESS2108)
Role: collaborator
Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)
Role: collaborator
A Combined Model Based on Spleen Stiffness, Liver Stiffness and Platelets for Assessing Portal Hypertension in Compensated Cirrhosis (CHESS2202)
Role: collaborator
Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106)
Role: collaborator
Baveno VI Criteria in Dynamic Monitoring of High-risk Varices in Compensated Cirrhotic Patients
Role: collaborator
An AI Model Based on Smartphone-derived Multimodality Images to Evaluate Portal Hypertension in Patients With Cirrhosis (CHESS2203)
Role: collaborator
Safety and Immunogenicity of COVID-19 Vaccine Booster in Patients With Liver Diseases
Role: collaborator
A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B
Role: collaborator
All 14 trials loaded